Answers are grounded in this paper and cite their sources.
A manufacturing process has been developed suitable for the production of 3‘-deoxyadenosine (cordycepin, 3‘-dA) in 20% yield from adenosine. The chemistry involves conversion of adenosine to isomeric 2‘,3‘-bromoacetates with isolation of the desired isomer in high purity. Acidic hydrolysis followed by hydrogenolysis afforded product with a purity of ≥99%. Unlike routes reported in the literature, intermediates are isolated as solids, thus avoiding the use of chromatography for isomer separation and final product purification.
No takes yet. Share an insight, caveat, or question.
Aman et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: